Home › Funds › NAN FUNG TRINITY (HK) Ltd › IMNM
NAN FUNG TRINITY (HK) Ltd position in IMNM
IMMUNOME INC · Health Care
NAN FUNG TRINITY (HK) Ltd reported holding 621,079 shares of IMNM (IMMUNOME INC) in its Q3 2026 13F filing — a position valued at US$13.4M, representing 1.28% of its reported portfolio and ranking #33 among its reported holdings. NAN FUNG TRINITY (HK) Ltd has disclosed IMNM holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How NAN FUNG TRINITY (HK) Ltd's IMNM position evolved
NAN FUNG TRINITY (HK) Ltd first disclosed a stake in IMNM in Q2 2025 at 548,850 shares (US$5.1M). The position peaked in Q1 2026 at 714,553 shares, worth US$15.6M. Across 6 filings, NAN FUNG TRINITY (HK) Ltd increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 621,079 shares valued at US$13.4M — a reduction of -93,474 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 548.85K | $5.10M | New |
| Q3 2025 | 592.10K | $6.93M | Add |
| Q4 2025 | 714.55K | $15.35M | Add |
| Q1 2026 | 714.55K | $15.63M | Hold |
| Q2 2026 | 714.55K | $15.14M | Hold |
| Q3 2026 | 621.08K | $13.36M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMNM and 13F data
IMNM (IMMUNOME INC) is a Health Care company. 42 other funds we track also report a position in IMNM — the largest reported positions include Redmile Group, LLC (US$104.1M), Enavate Sciences GP, LLC (US$76.6M), SILVERARC CAPITAL MANAGEMENT, LLC (US$45.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMNM
- Redmile Group, LLC 4.91M sh · $104.08M · Q2 2026
- Enavate Sciences GP, LLC 3.61M sh · $76.58M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 2.09M sh · $45.01M · Q3 2026
- Sofinnova Investments, Inc. 1.72M sh · $36.45M · Q2 2026
- READYSTATE ASSET MANAGEMENT LP 1.61M sh · $34.03M · Q2 2026
- Pivotal bioVenture Partners Investment Advisor LLC 732.51K sh · $15.52M · Q2 2026
- Parkman Healthcare Partners LLC 594.20K sh · $12.59M · Q2 2026
More on NAN FUNG TRINITY (HK) Ltd
FAQ
How long has NAN FUNG TRINITY (HK) Ltd held IMNM?
NAN FUNG TRINITY (HK) Ltd has disclosed IMNM holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is NAN FUNG TRINITY (HK) Ltd's current position in IMNM?
As of Q3 2026, NAN FUNG TRINITY (HK) Ltd holds 621.08K shares of IMNM (IMMUNOME INC), valued at $13.36M, representing 1.28% of its reported portfolio and ranking #33.
Has NAN FUNG TRINITY (HK) Ltd been buying or selling IMNM?
In the latest 13F filing (Q3 2026), NAN FUNG TRINITY (HK) Ltd reduced its position in IMNM. The position peaked in Q1 2026 at 714.55K shares.
Which other funds hold IMNM?
Other major institutional holders of IMNM include Redmile Group, LLC, Enavate Sciences GP, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.